|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,395.00 TWD | 0.00% |
|
+20.78% | +196.81% |
| 06-18 | PharmaEssentia Rebuffs Media Report Speculating Profit, Revenue for 2026 | MT |
| 06-11 | PharmaEssentia Completes Enrollment for Phase III Primary Myelofibrosis Drug Study | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | +20.78% | +55.17% | +120.73% | +196.81% | +178.93% | +360.74% | +1,663.18% | +662.64% | 16.22B | |
| +0.68% | +5.92% | +19.47% | +28.37% | +15.90% | +80.45% | +137.78% | +216.62% | +6,958.62% | 59.1B | |
| +2.32% | +5.03% | +25.56% | +24.13% | +36.94% | +75.51% | +94.88% | -19.95% | - | 55.19B | |
| +3.86% | +6.93% | +10.28% | +6.98% | +2.46% | -11.32% | -9.53% | -56.45% | - | 24.67B | |
| +4.30% | +7.95% | +7.45% | -31.29% | -35.88% | +14.11% | +437.83% | +291.58% | +1,006.05% | 24.19B | |
| +4.74% | +13.68% | +14.93% | +7.38% | +19.47% | +45.58% | -1.42% | -73.08% | - | 19.69B | |
| -0.29% | +9.78% | +22.60% | +6.26% | -7.82% | +44.62% | -27.94% | -28.22% | +51.05% | 17.56B | |
| +3.50% | +1.97% | +8.24% | +27.28% | +27.42% | +21.02% | +191.95% | +205.86% | +583.60% | 14.04B | |
| +6.72% | +19.38% | +25.19% | -0.89% | +27.23% | +42.82% | - | - | - | 14.84B | |
| +2.67% | +3.01% | +8.18% | -3.44% | -9.31% | +76.70% | +133.90% | +433.43% | - | 12.18B | |
| +7.23% | +10.06% | +2.32% | -20.43% | -11.84% | -37.19% | +537.19% | +98.97% | +98.46% | 11.97B | |
| +4.41% | +6.46% | +15.77% | +37.62% | +26.51% | +400.24% | +138.61% | +33.04% | +1,427.09% | 11.83B | |
| +1.44% | +5.23% | +22.32% | +29.61% | +36.12% | +149.54% | +159.26% | +319.65% | +795.34% | 11.74B | |
| +8.02% | +22.93% | -0.29% | -27.12% | -9.38% | -3.49% | +182.87% | +71.81% | - | 12.03B | |
| +2.61% | +8.38% | +31.48% | +29.32% | +376.77% | +247.06% | +244.53% | -32.52% | - | 9.89B | |
| +0.11% | +0.17% | +37.20% | +17.36% | +23.00% | +53.74% | +196.15% | - | - | 9.77B | |
| +9.68% | +26.06% | +19.70% | -23.78% | +21.94% | +48.94% | +157.10% | -24.44% | - | 10.06B | |
| +0.01% | +40.02% | +54.78% | +34.32% | +25.66% | +38.32% | +359.23% | +310.41% | - | 8.68B | |
| +4.12% | +3.31% | +24.42% | +0.02% | +26.55% | +75.61% | +18.65% | +156.21% | - | 8.43B | |
| -2.54% | -1.43% | +17.83% | +82.07% | +164.44% | +449.68% | +655.77% | -50.71% | -28.55% | 7.52B | |
| Average | +3.18% | +10.04% | +21.13% | +17.22% | +47.65% | +99.54% | +208.82% | +195.30% | +1,283.81% | 17.98B | |
| Weighted average by Cap. | +2.86% | +8.01% | +20.39% | +17.58% | +35.10% | +81.34% | +173.04% | +178.60% | +2,770.91% |
- Stock Market
- Stocks
- 6446 Stock
- Sector PharmaEssentia Corporation
Select your edition
All financial news and data tailored to specific country editions
